Scientists have uncovered how a molecule called spermine, naturally produced by the body, helps cells neutralize toxic protein buildups linked to Alzheimer’s and Parkinson’s. By encouraging these ...

Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...

In the first week of December, there was a 70 per cent jump in the number of lab-confirmed influenza cases in Alberta, along ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

Although the readout was only from four multiple myeloma patients, attendees at the meeting wondered at how far the CAR T-cell therapy field has come.

Researchers at UT Southwestern Medical Center have identified a protein that causes human cell membranes to break open in a ...

Healthcare in Miami is rapidly evolving with innovation at its core. Various stakeholders, from tech to philanthropy and faith-based organizations, are reshaping the landscape. Catch up with our ...

Health leaders believe the UK could face its worst flu season to date - with some hospitals already declaring critical ...

This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...

Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...

Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...

In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% ...